medline.ch Respirationstrakt Neoplasie

	The Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer. Oncol Res Petrella F, Cara A, Cassina EM, Libretti L, Pirondini E, Raveglia F, Sibilia MC, Tuoro A. PMID: 42065071 [PubMed - indexed for MEDLINE]
	Colorectal Cancer Complicated by Pulmonary Embolism and Potential Takotsubo Cardiomyopathy in a Person With Cystic Fibrosis: Diagnostic and Management Considerations. Respirol Case Rep Frederiksen L, Brown J, Moore V, Reid DW. PMID: 42065031 [PubMed]
	On the road to early detection: A survey study of barriers and facilitators to community participation in a mobile lung cancer screening program. medRxiv Cottrell-Daniels C, Sadig N, Haddan S, Roman S, Simmons VN, Schabath MB. PMID: 42064964 [PubMed]
	Novel risk models based on screening history results and timing of lung cancer diagnosis: Post hoc analysis of the National Lung Cancer Screening Trial. medRxiv Haddan SA, Waqas A, Rasool G, Schabath MB. PMID: 42064909 [PubMed]
	Effects of ACSM guideline-based exercise on patients with lung cancer: a systematic review and meta-analysis. Front Physiol Guo J, Wu B, Zhang Y, Li J, Shang S, Xu X, Xu D, Nie Y, Li Z, Sun W. PMID: 42064554 [PubMed]
	Deep ensemble of multi-head attention CNNs for histopathological image-based of lung and colon cancer diagnosis. Digit Health Rahman AKZR, Swapno SMMR, Raha AD, Biswas S, Khan S, Khushbu KG, Reza AW, Bairagi AK, Aloteibi S, Moni MA. PMID: 42064379 [PubMed]
	The landscape of lung cancer screening globally: a comparison of established programs and estimates of eligibility to participate. Lancet Reg Health West Pac Jongebloed H, Gao L, Yong HH, Livingston PM, White VM, Gartner CE, Fong GT, Hyland A, East KA, Przewozniak K, Seo HG, Kim Y, Milch V, Ugalde A. PMID: 42064324 [PubMed]
	A fusion model based on tumor and peritumoral CT radiomics for differentiating bronchiolar adenoma from lung adenocarcinoma. Front Oncol Zhao Z, Ke T, Xu Z, Zhou Y, Dong Y, Liu Y, Wu J, Wei W, Han D, Zhao W. PMID: 42063731 [PubMed]
	KRAS(G12C) inhibitors versus chemotherapy alone for KRAS(G12C)-mutated non-small cell lung cancer: a pooled analysis of CodeBreaK 200 and KRYSTAL-12 trials. Front Oncol Liang S, Li Y, Wan K, Zhang W, Xiong L. PMID: 42063697 [PubMed]
	Analysis of Somatic Mutations and Immunotherapy Biomarkers in Chinese Patients With Non-Small Cell Lung Cancer During 2019-2024: A Retrospective Study. Health Sci Rep Liu X, Chen W, Xin C, Wang Z, Yi K, Wang L, Liu J. PMID: 42063689 [PubMed]
	Systematic prioritisation of AI-detected chest X-ray abnormalities for optimised lung cancer detection. BJR Artif Intell Bramley RR, Sharman AC, Duerden R, Lyon S, Ryan M, Weber E, Brown L, Evison M. PMID: 42063602 [PubMed]
	Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients. Mil Med Res Wang CR, Li RD, Wang P, Dong XS, Zhang H, Zeng QP, Xie JX, Luo ZL, Chen XL, Zheng YD, Li JB, Xu YJ, Wang F, Li N, Tan FW, He J. PMID: 42063463 [PubMed - indexed for MEDLINE]
	Localized Microbial-Immunometabolic Interactions and Early Lung Cancer. Cancer Prev Res (Phila) Darawshy F, Segal LN. PMID: 42063308 [PubMed - indexed for MEDLINE]
	Revolutionizing lung cancer screening: the rise of artificial intelligence integrating circulating tumor markers. World J Surg Oncol Li H, Nan H, Sun Y, Zhao M, Qiu Y, Chen S, Wang Y. PMID: 42063042 [PubMed - as supplied by publisher]
	Correction to "Real-World Outcomes of Pembrolizumab Monotherapy in Metastatic Non-Small Cell Lung Cancer by Age and Sex: A National Population-Based Study in Australia". Clin Pharmacol Ther PMID: 42062778 [PubMed - as supplied by publisher]
	Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers? Ann Oncol Mavrikios A, Bortolot M, Le Péchoux C, Remon J, Botticella A, Aldea M, Brown PD, Rusthoven CG, Lavaud P, Frelaut M, Abdayem P, Lavigne D, Camps-Malea A, Besse B, Planchard D, Barlesi F, Jacob J, Gougis P, Knafo S, Chargari C, Dhermain F, Deutsch E, Faivre-Finn C, Levy A. PMID: 42061818 [PubMed - as supplied by publisher]
	CLO26-107: A Meta-Analysis and Network Meta-Analysis for Overall Survival of Pembrolizumab Monotherapy Versus Combined With Chemotherapy as First-Line Therapy in No EGFR/ALK-Mutation Advanced or Metastatic Non-Small-Cell Lung Cancer. J Natl Compr Canc Netw Yang W, Oh Y. PMID: 42061459 [PubMed - in process]
	Brief Report: A Pilot Study Evaluating the Feasibility, Safety, and Compliance With a Fasting-Mimicking Diet in Patients With Metastatic Non-Small Cell Lung Cancer. Clin Lung Cancer Ghaddar F, Ahmed S, Kirsch B, Jennewein L, Uhrich MM, Althouse SK, Longo V, Jalal S. PMID: 42060951 [PubMed - as supplied by publisher]
	Erratum: First-In-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01. J Clin Oncol Shimizu T, Sands J, Yoh K, Spira A, Garon EB, Kitazono S, Johnson ML, Meric-Bernstam F, Tolcher AW, Yamamoto N, Greenberg J, Kawasaki Y, Zebger-Gong H, Kobayashi F, Phillips P, Lisberg AE, Heist RS. PMID: 42060873 [PubMed - as supplied by publisher]
	Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial. JAMA Oncol Socinski MA, Stahel R, Lee DH, Cappuzzo F, Nishio M, Lovly CM, Ozyilkan O, Li Q, Johnson M, Garon EB, Kilickap S, Ferreira da Silva FA, Alatorre-Alexander J, Meng R, Amin R, Matheny C, Troutman S, Wen X, Patil NS, Zou W, Rodriguez-Abreu D. PMID: 42060297 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 159224

Seite 1 von 7962



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung